IQVIA Other Non-Current Liabilities decreased by 10.3% to $617.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 8.7%, from $676.00M to $617.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows relatively stable performance with a 1.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $607.00M | $656.00M | $649.00M | $581.00M | $563.00M | $561.00M | $671.00M | $641.00M | $703.00M | $679.00M | $698.00M | $595.00M | $632.00M | $612.00M | $668.00M | $676.00M | $671.00M | $698.00M | $688.00M | $617.00M |
| QoQ Change | — | +8.1% | -1.1% | -10.5% | -3.1% | -0.4% | +19.6% | -4.5% | +9.7% | -3.4% | +2.8% | -14.8% | +6.2% | -3.2% | +9.2% | +1.2% | -0.7% | +4.0% | -1.4% | -10.3% |
| YoY Change | — | — | — | — | -7.2% | -14.5% | +3.4% | +10.3% | +24.9% | +21.0% | +4.0% | -7.2% | -10.1% | -9.9% | -4.3% | +13.6% | +6.2% | +14.1% | +3.0% | -8.7% |